Neosporin Export Market Intelligence: India's 99 Suppliers Shipping to 62 Countries — TransData Nexus 2026

Q: Who are the top neosporin exporters from India?

The top neosporin exporters from India are: 1. PARAGON DIAGNOSTICS — $10.3K (10.3% market share); 2. ANBU AGENCIES — $10.3K (10.3% market share); 3. GET EXPORTS & IMPORTS SHOP — $9.8K (9.8% market share); 4. CAPSTONE EXPORT & IMPORT — $6.7K (6.7% market share); 5. VEA IMPEX (I) PRIVATE LIMITED — $6.4K (6.4% market share). Together they account for 43.5% of India's total neosporin export value.

Q: What is the total export value of neosporin from India?

The total export value of neosporin from India is $99.9K USD, recorded across 815 shipment transactions from 99 active exporters to 62 destination countries. The average shipment value is $123.

Q: Which countries import neosporin from India?

India exports neosporin to 62 countries worldwide. The top importing countries are: MALDIVES (38.9% share, $38.9K), SEYCHELLES (16.2% share, $16.2K), MICRONESIA (10.3% share, $10.3K), SAUDI ARABIA (3.4% share, $3.4K), SAINT KITTS AND NEVIS (2.7% share, $2.7K). These five markets account for 71.6% of total export value.

Q: What is the HS code for neosporin exports from India?

The primary HS code for neosporin exports from India is 30042099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of neosporin exports from India?

The average unit price for neosporin exports from India is $3.06 USD per unit, with prices ranging from $0.17 to $204.25 depending on formulation, packaging, and order volume. The total market is valued at $99.9K across 815 shipments.

Q: Which ports handle neosporin exports from India?

The primary ports for neosporin exports from India are SAHAR AIR CARGO ACC (INBOM4) (27.0% of shipments), SAHAR AIR (23.7% of shipments), CHENNAI AIR CARGO ACC (INMAA4) (8.7% of shipments), Bombay Air (6.7% of shipments), CHENNAI AIR (6.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of neosporin?

India is one of the world's leading exporters of neosporin due to its large base of 99 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports neosporin to 62 countries, demonstrating 32% global market coverage.

Q: What certifications do Indian neosporin exporters need?

Indian neosporin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import neosporin from India?

There are 253 registered buyers importing neosporin from India, spread across 62 countries. The repeat buyer rate is 58.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top neosporin supplier from India?

PARAGON DIAGNOSTICS is the leading neosporin exporter from India with a market share of 10.3% and total export value of $10.3K across 5 shipments. The top 5 suppliers together control 43.5% of total export value.

Suresh Sormare

Neosporin

India Pharmaceutical Trade Intelligence

$99.9K99 Suppliers62 CountriesHS 30042099

ExportsIndia → MALDIVES38.9%India → SEYCHELLES16.2%

Neosporin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Neosporin to the World

Between 2022 and 2026, India exported $99.9K worth of neosporin across 815 verified shipments to 62 countries — covering 32% of world markets in the Brand Names & OTC Products segment. The largest destination is MALDIVES (38.9%). PARAGON DIAGNOSTICS leads with a 10.3% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Neosporin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Neosporin export data snapshot — $99.9K · 99 exporters · 62 countriesTransData Nexus · Indian Customs Data

Top Neosporin Exporters from India

99 active exporters · Ranked by export value

View all 99 →

Top Neosporin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	PARAGON DIAGNOSTICS	$10.3K	5	1	10.3%
2	ANBU AGENCIES

Top Countries Importing Neosporin from India

62 destination markets · Ranked by import value

All 62 countries →

Top Countries Importing Neosporin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	MALDIVES	$38.9K	38.9%
2	SEYCHELLES	$16.2K	16.2%
3	MICRONESIA	$10.3K	10.3%
4	SAUDI ARABIA	$3.4K	3.4%
5	SAINT KITTS AND NEVIS	$2.7K	2.7%
6	SINGAPORE	$2.4K	2.4%
7	PAPUA NEW GUINEA	$2.3K	2.3%
8	UNITED ARAB EMIRATES	$2.0K	2.0%
9	CAYMAN ISLANDS	$2.0K	2.0%
10	BHUTAN	$2.0K	2.0%

MALDIVES is India's largest neosporin export destination, absorbing 38.9% of total exports worth $38.9K. The top 5 importing countries — MALDIVES, SEYCHELLES, MICRONESIA, SAUDI ARABIA, SAINT KITTS AND NEVIS — together account for 71.6% of India's total neosporin export value. The remaining 57 destination countries collectively receive the other 28.4%, indicating a broadly diversified export footprint across multiple regions.

Regulatory Landscape — Neosporin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, Neosporin is classified as an over-the-counter (OTC) medication, allowing consumers to purchase it without a prescription. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for generic versions of Neosporin's active ingredients, indicating a competitive market with several manufacturers. Notably, the FDA approved an ANDA for a generic version of Neosporin in March 2025, reflecting ongoing interest in this product category.

The substantial number of Indian exporters (99) involved in shipping Neosporin to the U.S. underscores India's significant role in supplying this product. However, exporters must adhere to stringent FDA regulations, including compliance with Current Good Manufacturing Practices (cGMP) and accurate labeling standards, to ensure market access and maintain product integrity.

2EU & UK Regulatory Framework

In the European Union, Neosporin's active ingredients require marketing authorization from the European Medicines Agency (EMA) before commercialization. The EMA mandates adherence to EU Good Manufacturing Practice (GMP) guidelines to ensure product quality and safety. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the approval process, necessitating compliance with UK-specific GMP standards.

As of March 2026, there have been no recent EMA or MHRA actions specifically concerning Neosporin, indicating stable regulatory standing within these jurisdictions.

3WHO Essential Medicines & Global Standards

The World Health Organization (WHO) includes the combination of neomycin and bacitracin on its Model List of Essential Medicines, recognizing their importance in basic healthcare systems. This inclusion underscores the global significance of these antibiotics in treating bacterial infections. Additionally, Neosporin's active ingredients are standardized in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality benchmarks across different regions.

4India Regulatory Classification

In India, Neosporin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for Neosporin, allowing market-driven pricing. For export purposes, Indian manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national export regulations.

5Patent & Exclusivity Status

The original patents for Neosporin's formulation have expired, leading to the availability of generic versions in various markets. This expiration has intensified competition among manufacturers, including Indian exporters, who now supply Neosporin to a diverse range of countries.

6Recent Industry Developments

In June 2025, the WHO updated its Model List of Essential Medicines, reaffirming the inclusion of neomycin and bacitracin, highlighting their continued relevance in global healthcare. In September 2025, the FDA approved a new generic version of Neosporin, further increasing market competition. Additionally, in December 2025, the Indian Ministry of Health and Family Welfare introduced revised GMP guidelines, aligning more closely with international standards, impacting manufacturers of Neosporin and similar products.

These developments reflect the dynamic nature of the pharmaceutical industry, emphasizing the need for exporters to stay informed about regulatory changes and market trends to maintain compliance and competitiveness.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Neosporin

Retail & reference prices across 9 markets vs. India FOB export price of $3.06/unit

Global Price Benchmark for Neosporin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$5.99	USD	Pricing data sourced from the U.S. Food and Drug Administration (FDA) and reflects average retail prices as of March 2026.
United Kingdom	$5.85	GBP	According to the National Health Service (NHS) Drug Tariff, Neosporin is listed under proprietary preparations with the specified pricing.
Germany	$5.50	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) provides pricing information for over-the-counter medications, including Neosporin.
Australia

Supply Chain Risk Assessment — Neosporin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

The production of Neosporin relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs), many of which are sourced from China. According to the U.S. Pharmacopeia, 41% of KSMs used for U.S.-approved APIs are solely sourced from China, while 16% come from India. This heavy reliance on Chinese suppliers poses a significant risk, as any disruption in China's production capabilities—due to environmental regulations, trade restrictions, or geopolitical tensions—could severely impact the availability of essential raw materials for Neosporin manufacturing.

Furthermore, the complex and hazardous nature of KSM production makes it challenging to relocate these manufacturing processes to other countries. China's dominance in this sector means that even if API production occurs in India, the dependency on Chinese KSMs remains a critical vulnerability in the supply chain.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of Neosporin account for 43.5% of total exports, with PARAGON DIAGNOSTICS leading at a 10.3% share. This concentration suggests a moderate risk, as disruptions affecting these key suppliers could impact a significant portion of Neosporin exports.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) Scheme for Pharmaceuticals, aiming to boost domestic manufacturing of critical APIs and reduce import dependency. As of September 2025, the scheme has led to the creation of manufacturing capacities for 26 KSMs and APIs, resulting in cumulative sales of ₹2,315 crore and avoiding imports worth ₹1,807 crore.

Access Complete Neosporin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 815 transactions across 62 markets.

Request Demo View Pricing

Frequently Asked Questions — Neosporin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top neosporin exporters from India?

The leading neosporin exporters from India are PARAGON DIAGNOSTICS, ANBU AGENCIES, GET EXPORTS & IMPORTS SHOP, and 10 others. PARAGON DIAGNOSTICS leads with 10.3% market share ($10.3K). The top 5 suppliers together control 43.5% of total export value.

What is the total export value of neosporin from India?

The total export value of neosporin from India is $99.9K, recorded across 815 shipments from 99 active exporters to 62 countries. The average shipment value is $123.

Which countries import neosporin from India?

India exports neosporin to 62 countries. The top importing countries are MALDIVES (38.9%), SEYCHELLES (16.2%), MICRONESIA (10.3%), SAUDI ARABIA (3.4%), SAINT KITTS AND NEVIS (2.7%), which together account for 71.6% of total export value.

What is the HS code for neosporin exports from India?

The primary HS code for neosporin exports from India is 30042099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Neosporin

Neosporin

How India Exports Neosporin to the World

Top Neosporin Exporters from India

Top Countries Importing Neosporin from India

Quick Facts

Related Brand Names & OTC Products

Related Analysis

Need Details?

Regulatory Landscape — Neosporin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Neosporin

Supply Chain Risk Assessment — Neosporin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Neosporin Trade Intelligence

Frequently Asked Questions — Neosporin Exports from India

Who are the top neosporin exporters from India?

What is the total export value of neosporin from India?

Which countries import neosporin from India?

What is the HS code for neosporin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of neosporin exports from India?

Which ports handle neosporin exports from India?

Why is India a leading exporter of neosporin?

What certifications do Indian neosporin exporters need?

How many buyers import neosporin from India?

What is the market share of the top neosporin exporter from India?

Analysis Methodology